Skip to main content

Ozempic®

(semaglutide) injection 0.5 mg, 1 mg, 2 mg

Ozempic® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If Ozempic® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 56 days. Ozempic® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.1

 

Recommended Storage Conditions for Ozempic®1

 

 Before First Use  After First Use 
 Refrigerated (36 °F – 46 °F)  Room Temperature
 (59 °F – 86 °F)  Refrigerated
 (36 °F – 46 °F) 
 Until expiration date  56 days  56 days 

Ozempic® / Rybelsus® tablets

Ozempic® (semaglutide) tablets 4 mg or 9 mg, Rybelsus® (semaglutide) tablets 7 mg or 14 mg

Rybelsus® and Ozempic® tablets should be stored at 68°F to 77°F (20°C to 25°C); excursions permitted to 59°F to 86°F (15°C to 30°C) (see USP Controlled Room Temperature). Rybelsus® and Ozempic® tablets should be stored and dispensed in the original bottle until use to protect tablets from moisture.

Rybelsus® and Ozempic® tablets should not be stored in any other container. Store Rybelsus® and Ozempic® tablets in a dry place away from moisture.2

 

Recommended Storage Conditions for Ozempic® / Rybelsus® tablets

 

Before First Use After First Use 
 Room Temperature
 (68 °F – 77 °F) Room Temperature
 (68 °F – 77 °F) 
 Until expiration date Until expiration date 

Saxenda®

(liraglutide) injection 3 mg

Saxenda® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If Saxenda® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 30 days. Saxenda® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.3

 

Recommended Storage Conditions for Saxenda®3

 

 Before First Use  After First Use 
 Refrigerated (36 °F – 46 °F)  Room Temperature
 (59 °F – 86 °F)  Refrigerated
 (36 °F – 46 °F) 
 Until expiration date  30 days  30 days 

Victoza®

(liraglutide) injection 1.2 mg, 1.8 mg

Victoza® can be used as long as the product has not been exposed to temperatures below 36 °F or above 86 °F. If unopened Victoza® was exposed to non-refrigerated temperatures (any temperature above 46 °F), the product must be used or discarded within 30 days. Victoza® should be inspected for changes such as precipitation, or change in color or clarity that may indicate a loss in potency.4

 

Recommended Storage Conditions for Victoza®4

 

 Before First Use After First Use 
 Refrigerated (36 °F – 46 °F)  Room Temperature
 (59 °F – 86 °F)  Refrigerated
 (36 °F – 46 °F) 
 Until expiration date  30 days  30 days 

Wegovy®

(semaglutide) injection 1.7 mg, 2.4 mg, 7.2 mg

(semaglutide) tablet 25 mg

Wegovy® injection: Store the Wegovy® single-dose pen in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days. Do not store Wegovy® in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze Wegovy® and do not use if it has been frozen. Protect Wegovy® from light. Wegovy® must be kept in the original carton until time of administration. Discard the Wegovy® pen after use.5

 

Wegovy® Tablet: Store at 68°F to 77°F; excursions permitted to 59°F to 86°F. Store and dispense Wegovy® tablets in the original bottle. Store Wegovy® tablet in the original bottle until use to protect tablets from moisture. Store Wegovy® tablets in a dry place away from moisture.5

 

Recommended Storage Conditions for Wegovy® Injection5

 

 Before First Use         After First Use         
 Refrigerated (36 °F – 46 °F)  46 °F – 86 °F) 
 Until expiration date  Up to 28 days 

 

Recommended Storage Conditions for Wegovy® Tablet5

 

 Before First Use  After First Use 
 Room Temperature (68 °F – 77 °F)  Room Temperature
 (68 °F – 77 °F) 
 Until expiration date  Until expiration date 

References

  1. Ozempic® Prescribing Information. Plainsboro, NJ: Novo Nordisk.
  2. Ozempic® / Rybelsus® tablets Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
  3. Saxenda® Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
  4. Victoza® Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.
  5. Wegovy® Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc.

Find more information

Contact icon

Speak to a medical representative

If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.

Microscope icon

Search the Medical Information Database

Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.